FUNDAMENTALS OF CHEMOTHERAPY IMMUNOTHERAPY
ADMINISTRATION EXAM LATEST 2024 ACTUAL EXAM
*A patient is scheduled to begin cetuximab. The nurse should teach the patient
about the importance of using:
A. Alcohol based cleansers
B. Hypoallergenic moisturizers
C. Pure petrolleum*
D. Benzoyl peroxide gel - ANSWER: C. Pure petrolleum*
*Which of the following medications is known to be carcinogenic to humans?
A. Streptozocin
B. Bleomycin
C. Melphalan*
D. Daunorubicin - ANSWER: C. Melphalan
*Which of the following actions could help improve adherence to oral
chemotherapeutic medications?
A. Providing the benefits of adherence at the first clinic appointment.*
B. Teaching the patient how to use a pillbox to store medication.
C. Encouraging the patient to move in with a family member.
D. Ongoing collaboration between the patient and healthcare team. - ANSWER: B.
Teaching the patient how to use a pillbox to store medication.
*A patient with a history of receiving chest radiation is scheduled to receive a second
cycle of doxorubicin. The nurse notes that the patient's cumulative dose of
doxorubicin before this cycle is 440mg/m2. The nurse's initial response is to:
A. Anticipate a referral for the patient to cardiology
B. Notify the physician of the cumulative dose.*
C. Cancel the patient's chemotherapy appointment
D. Administer the chemotherapy as ordered. - ANSWER: A. Anticipate a referral for
the patient to cardiology
What type of analgesia is used to access an implanted port for vesicant
administration?
A. Subcutaneous lidocaine
B. Intradermal bacteriostatic saline
C. Intradermal lidocaine
D. Topical short acting anesthesic* - ANSWER: D. Topical short acting anesthesic*
A patient receiving an infusion of mitomycin reports slight discomfort above the
peripheral IV site. What is an appropriate action for the nurse to take?
A. Restart the IV below the previous site.
B. Wrap the arm in a warm blanket
C. Reduce the infusion rate and monitor the site.
, D. Stop the infusion and aspirate for a blood return.* - ANSWER: D. Stop the infusion
and aspirate for a blood return.*
A patient's IV infiltrates. The nurse restarts the IV in:
A. A site proximal to the previous site.
B. A lower extremity.
C. The ventral surface of the wrist.
D. The antecubital fossa.* - ANSWER: D. The antecubital fossa.*
*Which statement by a patient indicates the need for additional teaching regarding
the side effects doxorubicin? "I need to report any..."
A. Fever above 100.5
B. Shortness of breath
C. Changes in the color of urine*
D. Sudden weight gain - ANSWER: C. Changes in the color of urine*
A patient reports leaking at the chemotherapy infusion site. After assessing and
warning others, the nurse:
A. Consults the pharmacist for instructions
B. Relocates the patient to another room
C. Contacts the physician for additional orders.
D. Retrieves the hazardous medication spill kit.* - ANSWER: D. Retrieves the
hazardous medication spill kit.*
A patient on flourouracil reports flaky, painful hands. What does the nurse suspect?
A. Flair reaction to the treatment.
B. Holt-Oram syndrome
C. Palmar-plantar erythrodysesthesia*
D. Hypersensitivity reaction - ANSWER: C. Palmar-plantar erythrodysesthesia*
Which of the following information is included in a sorafenib teaching plan?
A. Agent is an IV medication that does not require routine premedications.
B. Doses are taken at least 1 hour before or two hours after a meal.*
C. Elevated calcium levels are monitored after the first and before the third cycles.
D. Baseline ejection fraction is obtained prior to initial treatment. - ANSWER: B.
Doses are taken at least 1 hour before or two hours after a meal.*
The lifetime cumulative doxorubicin dose is 450 mg/m2 when a patient has received:
A. Chest irradiation
B. Bleomycin
C. Bracytherapy
D. Rituximab* - ANSWER: A. Chest irradiation
Oncogenes occur when there is mutation in the:
A. DNA*
B. Epidermal growth factor
C. RNA
ADMINISTRATION EXAM LATEST 2024 ACTUAL EXAM
*A patient is scheduled to begin cetuximab. The nurse should teach the patient
about the importance of using:
A. Alcohol based cleansers
B. Hypoallergenic moisturizers
C. Pure petrolleum*
D. Benzoyl peroxide gel - ANSWER: C. Pure petrolleum*
*Which of the following medications is known to be carcinogenic to humans?
A. Streptozocin
B. Bleomycin
C. Melphalan*
D. Daunorubicin - ANSWER: C. Melphalan
*Which of the following actions could help improve adherence to oral
chemotherapeutic medications?
A. Providing the benefits of adherence at the first clinic appointment.*
B. Teaching the patient how to use a pillbox to store medication.
C. Encouraging the patient to move in with a family member.
D. Ongoing collaboration between the patient and healthcare team. - ANSWER: B.
Teaching the patient how to use a pillbox to store medication.
*A patient with a history of receiving chest radiation is scheduled to receive a second
cycle of doxorubicin. The nurse notes that the patient's cumulative dose of
doxorubicin before this cycle is 440mg/m2. The nurse's initial response is to:
A. Anticipate a referral for the patient to cardiology
B. Notify the physician of the cumulative dose.*
C. Cancel the patient's chemotherapy appointment
D. Administer the chemotherapy as ordered. - ANSWER: A. Anticipate a referral for
the patient to cardiology
What type of analgesia is used to access an implanted port for vesicant
administration?
A. Subcutaneous lidocaine
B. Intradermal bacteriostatic saline
C. Intradermal lidocaine
D. Topical short acting anesthesic* - ANSWER: D. Topical short acting anesthesic*
A patient receiving an infusion of mitomycin reports slight discomfort above the
peripheral IV site. What is an appropriate action for the nurse to take?
A. Restart the IV below the previous site.
B. Wrap the arm in a warm blanket
C. Reduce the infusion rate and monitor the site.
, D. Stop the infusion and aspirate for a blood return.* - ANSWER: D. Stop the infusion
and aspirate for a blood return.*
A patient's IV infiltrates. The nurse restarts the IV in:
A. A site proximal to the previous site.
B. A lower extremity.
C. The ventral surface of the wrist.
D. The antecubital fossa.* - ANSWER: D. The antecubital fossa.*
*Which statement by a patient indicates the need for additional teaching regarding
the side effects doxorubicin? "I need to report any..."
A. Fever above 100.5
B. Shortness of breath
C. Changes in the color of urine*
D. Sudden weight gain - ANSWER: C. Changes in the color of urine*
A patient reports leaking at the chemotherapy infusion site. After assessing and
warning others, the nurse:
A. Consults the pharmacist for instructions
B. Relocates the patient to another room
C. Contacts the physician for additional orders.
D. Retrieves the hazardous medication spill kit.* - ANSWER: D. Retrieves the
hazardous medication spill kit.*
A patient on flourouracil reports flaky, painful hands. What does the nurse suspect?
A. Flair reaction to the treatment.
B. Holt-Oram syndrome
C. Palmar-plantar erythrodysesthesia*
D. Hypersensitivity reaction - ANSWER: C. Palmar-plantar erythrodysesthesia*
Which of the following information is included in a sorafenib teaching plan?
A. Agent is an IV medication that does not require routine premedications.
B. Doses are taken at least 1 hour before or two hours after a meal.*
C. Elevated calcium levels are monitored after the first and before the third cycles.
D. Baseline ejection fraction is obtained prior to initial treatment. - ANSWER: B.
Doses are taken at least 1 hour before or two hours after a meal.*
The lifetime cumulative doxorubicin dose is 450 mg/m2 when a patient has received:
A. Chest irradiation
B. Bleomycin
C. Bracytherapy
D. Rituximab* - ANSWER: A. Chest irradiation
Oncogenes occur when there is mutation in the:
A. DNA*
B. Epidermal growth factor
C. RNA
